Key terms
About CATX
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CATX news
Apr 01
7:53am ET
Perspective Therapeutics price target raised to $1.50 from $1.20 at Oppenheimer
Mar 28
7:33am ET
Perspective Therapeutics sees cash runway into 2026
Mar 28
7:33am ET
Perspective Therapeutics reports 2023 EPS (17c) vs. (8c) last year
Mar 27
12:30pm ET
Analysts Are Bullish on These Healthcare Stocks: 89bio (ETNB), Perspective Therapeutics (CATX)
Mar 21
7:27am ET
Buy Rating Affirmed for Perspective Therapeutics Amid Clinical Success and Strategic Partnerships
Mar 19
8:03am ET
Analysts Are Bullish on These Healthcare Stocks: Perspective Therapeutics (CATX), Neurogene (NGNE)
Mar 18
9:50am ET
Perspective Therapeutics to host analyst day
Mar 18
8:15am ET
Perspective Therapeutics announces collaboration agreement with Bristol Myers
Mar 18
4:55am ET
Perspective Therapeutics to host analyst day
Mar 18
4:55am ET
Perspective Therapeutics to host analyst day
Mar 17
2:38pm ET
Perspective Therapeutics to host analyst day
Mar 12
7:40am ET
5 Stocks Corporate Insiders are Buying in March 2024
Mar 11
3:35pm ET
Fly Insider : Echostar, Dell among week’s notable insider trades
Mar 06
7:50am ET
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Perspective Therapeutics (CATX)
Mar 05
8:15am ET
Perspective Therapeutics acquires CGMP-compliant manufacturing facility
Mar 04
10:00am ET
Perspective Therapeutics Inc trading resumes
Mar 04
9:46am ET
Perspective Therapeutics sells 92M shares at 95c in private placement
Mar 04
9:29am ET
Perspective Therapeutics Inc trading halted, news pending
Feb 06
4:59am ET
Perspective Therapeutics Updates Corporate Presentation Online
Feb 05
3:56pm ET
Fly Insider: Skye Bioscience, Coinbase among week’s notable insider trades
Feb 01
8:10am ET
Perspective introduces ‘pre-targeting’ Theranostic Technology Platform
Jan 29
3:48pm ET
Fly Insider: Edgewise, Arch Resources among week’s notable insider trades
Jan 29
3:48pm ET
Fly Insider: Edgewise,Arch Resources among week’s notable insider trades
Jan 26
8:13am ET
Perspective Therapeutics initiated with a Buy at B. Riley
Jan 22
2:47pm ET
Oppenheimer Remains a Buy on Perspective Therapeutics (CATX)
Jan 18
8:16am ET
Perspective Therapeutics 132.08M share Spot Secondary priced at $0.37
Jan 18
7:06am ET
Perspective Therapeutics prices 132.08M shares at 37c in public offering
Jan 17
4:08pm ET
Perspective Therapeutics announces common stock, warrants offering
Jan 17
8:06am ET
Perspective Therapeutics begins recruitment of second dosing cohorts
Jan 09
8:19am ET
Perspective Therapeutics enters strategic agreements with Lantheus
Jan 09
8:10am ET
Lantheus expands radiopharmaceutical oncology pipeline via agreements
No recent press releases are available for CATX
CATX Financials
Key terms
Ad Feedback
CATX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CATX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range